Year | Detail |
1888 |
Production of “alkaloidal” medicine granules. |
1894 |
Incorporated as the Abbott Alkaloidal Company. |
1907 |
Business Expansion In London, U.K. |
1916 |
Production of our first synthetic medicine, Chlorazene. |
1929 |
Initial public offering provides shares. |
1935 |
Introduction of Pentothal. |
1942 |
Abbott joins pharmaceutical makers to increase production of penicillin. |
1959 |
Adoption of Abbott "A" logo. |
1964 |
Acquisition of M&R Dietetics. |
1972 |
Introduction of the ABA-100 blood chemistry analyzer as well as Ausria. |
1985 |
Approval of licensed test to identify the HIV virus in blood. |
1998 |
Introduction of Glucerna. |
2002 |
FDA approval of Humira. |
2006 |
Launch of the Xience . |
2010 |
Recognized as the largest pharmaceutical company in India. |
2014 |
Launched glucose monitoring system FreeStyle Libre.
|
2016 |
Launched Alinity series a diagnostics and informatics systems. |
2017 |
Abbott acquired St. Jude Medical which was a largest acquisition ever. |
2017 |
Abbott acquired Alere Inc. |
2020 |
Abbott launched multiple COVID-19 diagnostic tests following the outbreak. |
2021 |
Abbott acquired Walk Vascular, LLC. |
2022 |
Abbott introduced Lingo. |
2023 |
Abbott received approval from the FDA for Aveir DR. |